Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 1991;105(4):453-8.
doi: 10.1007/BF02244363.

Comparison of the effects of mianserin and its enantiomers and metabolites on a behavioral screen for antidepressant activity

Affiliations
Comparative Study

Comparison of the effects of mianserin and its enantiomers and metabolites on a behavioral screen for antidepressant activity

T H Hand et al. Psychopharmacology (Berl). 1991.

Abstract

The behavioral effects of racemic mianserin, its (+) and (-) enantiomers, and its metabolites desmethylmianserin and 8-hydroxymianserin were evaluated on the differential-reinforcement-of-low-rate 72-s (DRL 72-s) schedule, a screen known to be sensitive to and specific for the antidepressant properties of drugs. Racemic mianserin produced the antidepressant-like effect (increased reinforcement rate, decreased response rate) at 5 and 10 mg/kg. The mianserin enantiomers showed the antidepressant-like effect beginning at lower doses [(+) mianserin; 0.6 mg/kg; (-) mianserin: 2.5 mg/kg]. The mianserin metabolites showed no clear dose-related effect at doses up to 10 mg/kg. It is concluded that the antidepressant-like effects of mianserin are due to the activity of the parent compound rather than to its metabolites, and that they may be primarily attributable to the (+) enantiomer. The greater potency of (+)-mianserin may be related to its higher affinity for the 5-HT2 receptor.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Naunyn Schmiedebergs Arch Pharmacol. 1977 Oct;300(1):31-7 - PubMed
    1. Br J Pharmacol. 1988 May;94(1):137-47 - PubMed
    1. Psychopharmacology (Berl). 1976 Sep 17;49(2):201-4 - PubMed
    1. Psychopharmacology (Berl). 1989;99(1):64-9 - PubMed
    1. Eur J Pharmacol. 1987 Jan 13;133(2):199-204 - PubMed

Publication types

LinkOut - more resources